Filed: 2/13/2025ACC: 0001839882-25-008942
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 83 equity positions with a total reported market value of $746.01M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
83
Positions
$746.01M
Total AUM (reported)
107.91M
Total Shares
Allocation by class
COM$342.63M45.9%
SPONSORED ADS$83.76M11.2%
S&P BIOTECH$67.55M9.1%
SHS$50.19M6.7%
COM NEW$39.96M5.4%
COMMON STOCK$32.59M4.4%
CL A$17.97M2.4%
Portfolio Concentration
Top 3$155.27M20.8%
4–10$197.02M26.4%
11–25$224.88M30.1%
Rest$168.84M22.6%
Top 3 weight
20.8%
Top 10 weight
47.2%
Voting Authority Distribution
Total shares with voting rights: 107.91M
Sole
Full voting authority
107.91M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole83
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings83
Rows:
SPDR SER TR
SOLEShares750K
TypeSH
Market value$67.55M
9.05%
Sole
750K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares1.16M
TypeSH
Market value$45.52M
6.10%
Sole
1.16M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares931.73K
TypeSH
Market value$42.21M
5.66%
Sole
931.73K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares425K
TypeSH
Market value$32.59M
4.37%
Sole
425K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares1.10M
TypeSH
Market value$31.64M
4.24%
Sole
1.10M
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares1.40M
TypeSH
Market value$30.86M
4.14%
Sole
1.40M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares660K
TypeSH
Market value$30.65M
4.11%
Sole
660K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares82.50K
TypeSH
Market value$25.46M
3.41%
Sole
82.50K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares460K
TypeSH
Market value$23.52M
3.15%
Sole
460K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares285K
TypeSH
Market value$22.31M
2.99%
Sole
285K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares824.33K
TypeSH
Market value$19.19M
2.57%
Sole
824.33K
Shared
0.00
None
0.00
WAVE LIFE SCIENCES LTD
SOLEShares1.50M
TypeSH
Market value$18.55M
2.49%
Sole
1.50M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares1.10M
TypeSH
Market value$18.36M
2.46%
Sole
1.10M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares425K
TypeSH
Market value$17.97M
2.41%
Sole
425K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares940.08K
TypeSH
Market value$17.71M
2.37%
Sole
940.08K
Shared
0.00
None
0.00
MESOBLAST LTD
SOLEShares838.60K
TypeSH
Market value$16.60M
2.23%
Sole
838.60K
Shared
0.00
None
0.00
MERUS N V
SOLEShares389.24K
TypeSH
Market value$16.37M
2.19%
Sole
389.24K
Shared
0.00
None
0.00
COHERUS BIOSCIENCES INC
SOLEShares16.63M
TypePRN
Market value$16.19M
2.17%
Sole
16.63M
Shared
0.00
None
0.00
OMEROS CORP
SOLEShares15.53M
TypePRN
Market value$14.61M
1.96%
Sole
15.53M
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares279.44K
TypeSH
Market value$12.87M
1.73%
Sole
279.44K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares630K
TypeSH
Market value$12.08M
1.62%
Sole
630K
Shared
0.00
None
0.00
KARYOPHARM THERAPEUTICS INC
SOLEShares15.25M
TypePRN
Market value$11.87M
1.59%
Sole
15.25M
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares3.97M
TypeSH
Market value$11.00M
1.47%
Sole
3.97M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares425K
TypeSH
Market value$10.92M
1.46%
Sole
425K
Shared
0.00
None
0.00
AUTOLUS THERAPEUTICS PLC
SOLEShares4.50M
TypeSH
Market value$10.57M
1.42%
Sole
4.50M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SER TRSOLE | S&P BIOTECH | 750K | SH | $67.55M 9.05% | 750K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 1.16M | SH | $45.52M 6.10% | 1.16M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 931.73K | SH | $42.21M 5.66% | 931.73K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 425K | SH | $32.59M 4.37% | 425K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 1.10M | SH | $31.64M 4.24% | 1.10M | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 1.40M | SH | $30.86M 4.14% | 1.40M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 660K | SH | $30.65M 4.11% | 660K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 82.50K | SH | $25.46M 3.41% | 82.50K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 460K | SH | $23.52M 3.15% | 460K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 285K | SH | $22.31M 2.99% | 285K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 824.33K | SH | $19.19M 2.57% | 824.33K | 0.00 | 0.00 |
WAVE LIFE SCIENCES LTDSOLE | SHS | 1.50M | SH | $18.55M 2.49% | 1.50M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 1.10M | SH | $18.36M 2.46% | 1.10M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 425K | SH | $17.97M 2.41% | 425K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 940.08K | SH | $17.71M 2.37% | 940.08K | 0.00 | 0.00 |
MESOBLAST LTDSOLE | SPONS ADR | 838.60K | SH | $16.60M 2.23% | 838.60K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 389.24K | SH | $16.37M 2.19% | 389.24K | 0.00 | 0.00 |
COHERUS BIOSCIENCES INCSOLE | NOTE 1.500% 4/1 | 16.63M | PRN | $16.19M 2.17% | 16.63M | 0.00 | 0.00 |
OMEROS CORPSOLE | NOTE 5.250% 2/1 | 15.53M | PRN | $14.61M 1.96% | 15.53M | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 279.44K | SH | $12.87M 1.73% | 279.44K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 630K | SH | $12.08M 1.62% | 630K | 0.00 | 0.00 |
KARYOPHARM THERAPEUTICS INCSOLE | NOTE 3.000%10/1 | 15.25M | PRN | $11.87M 1.59% | 15.25M | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 3.97M | SH | $11.00M 1.47% | 3.97M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 425K | SH | $10.92M 1.46% | 425K | 0.00 | 0.00 |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 4.50M | SH | $10.57M 1.42% | 4.50M | 0.00 | 0.00 |
Page 1 of 4